Boston Common Asset Management LLC Has $21.32 Million Stock Position in Colgate-Palmolive Company $CL

Key Points

• Boston Common Asset Management increased its Colgate-Palmolive stake by 7.1% in the first quarter, adding 16,502 shares to bring its total to 250,152 shares valued at about $21.32 million.
• Analyst sentiment on CL remains positive overall, with 12 Buy ratings and 7 Hold ratings, giving the stock a Moderate Buy consensus and a $97.41 average target price.
• Colgate-Palmolive recently beat quarterly expectations, posting $0.97 EPS and $5.32 billion in revenue, and it also announced a quarterly dividend of $0.53 per share payable on August 14.

Boston Common Asset Management LLC lifted its position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 7.1% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 250,152 shares of the company's stock after acquiring an additional 16,502 shares during the quarter. Colgate-Palmolive makes up about 1.4% of Boston Common Asset Management LLC's investment portfolio, making the stock its 15th largest position. Boston Common Asset Management LLC's holdings in Colgate-Palmolive were worth $21,320,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Kemnay Advisory Services Inc. acquired a new position in Colgate-Palmolive during the 4th quarter valued at about $25,000. CBIZ Investment Advisory Services LLC raised its stake in shares of Colgate-Palmolive by 86.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company's stock worth $26,000 after buying an additional 150 shares during the last quarter. TD Capital Management LLC lifted its holdings in Colgate-Palmolive by 61.4% in the fourth quarter. TD Capital Management LLC now owns 326 shares of the company's stock valued at $26,000 after buying an additional 124 shares during the period. Triumph Capital Management lifted its holdings in Colgate-Palmolive by 62.9% in the fourth quarter. Triumph Capital Management now owns 329 shares of the company's stock valued at $26,000 after buying an additional 127 shares during the period. Finally, Jessup Wealth Management Inc bought a new position in Colgate-Palmolive in the fourth quarter valued at approximately $26,000. Institutional investors own 80.41% of the company's stock.

Analyst Ratings Changes

CL has been the subject of several recent research reports. Rothschild & Co Redburn set a $100.00 target price on shares of Colgate-Palmolive and gave the company a "buy" rating in a research report on Tuesday, April 21st. Wells Fargo & Company lifted their price objective on Colgate-Palmolive from $92.00 to $95.00 and gave the stock an "equal weight" rating in a research note on Wednesday, July 8th. Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Sunday, March 29th. JPMorgan Chase & Co. increased their target price on Colgate-Palmolive from $96.00 to $104.00 and gave the company an "overweight" rating in a research note on Thursday. Finally, Morgan Stanley restated an "overweight" rating on shares of Colgate-Palmolive in a research report on Monday, May 4th. Twelve research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $97.41.

Colgate-Palmolive Stock Down 0.2%

Colgate-Palmolive stock opened at $92.84 on Monday. The company has a 50 day moving average of $90.46 and a 200-day moving average of $88.60. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The stock has a market capitalization of $74.29 billion, a PE ratio of 36.12, a price-to-earnings-growth ratio of 4.90 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, May 1st. The company reported $0.97 EPS for the quarter, topping analysts' consensus estimates of $0.94 by $0.03. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.22 billion. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The firm's quarterly revenue was up 8.4% on a year-over-year basis. During the same period last year, the business posted $0.91 earnings per share. On average, equities research analysts anticipate that Colgate-Palmolive Company will post 3.81 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be issued a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Monday, July 20th. Colgate-Palmolive's payout ratio is 82.49%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.